Niki Katsiki Selected Research

Brain Infarction

4/2022	Optimal management of asymptomatic carotid stenosis in 2021: the jury is still out. An international, multispecialty, expert review and position statement.
1/2022	Optimal Management of Asymptomatic Carotid Stenosis in 2021: The Jury is Still Out. An International, Multispecialty, Expert Review and Position Statement.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Niki Katsiki Research Topics

Disease

33	Non-alcoholic Fatty Liver Disease 06/2022 - 11/2011
33	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2009
33	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2008
22	Inflammation (Inflammations) 01/2022 - 01/2010
22	Obesity 12/2020 - 10/2008
22	Insulin Resistance 11/2020 - 10/2010
20	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2020 - 01/2011
18	Stroke (Strokes) 11/2022 - 07/2011
15	Heart Failure 10/2022 - 09/2012
15	Atherosclerosis 01/2021 - 02/2009
14	Chronic Renal Insufficiency 01/2020 - 12/2011
13	Hypertension (High Blood Pressure) 01/2019 - 10/2008
12	Coronary Disease (Coronary Heart Disease) 01/2022 - 04/2012
11	Alcoholic Fatty Liver 01/2019 - 08/2012
9	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2013
9	Coronary Artery Disease (Coronary Atherosclerosis) 09/2018 - 06/2013
8	Weight Loss (Weight Reduction) 01/2020 - 06/2011
7	COVID-19 01/2022 - 01/2020
6	Fatty Liver 01/2022 - 12/2011
6	Peripheral Arterial Disease 01/2021 - 12/2017
5	Transient Ischemic Attack 04/2022 - 01/2017
5	Diabetes Mellitus 01/2022 - 01/2015
5	Neoplasms (Cancer) 08/2020 - 09/2018
5	Vascular Diseases (Vascular Disease) 07/2018 - 01/2016
5	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2017 - 07/2009
5	Body Weight (Weight, Body) 01/2017 - 12/2010
4	Hyperglycemia 08/2021 - 12/2010
4	Thrombosis (Thrombus) 02/2021 - 07/2018
4	Diabetes Complications 02/2020 - 01/2014
3	Metabolic Diseases (Metabolic Disease) 12/2021 - 01/2014
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2021 - 01/2018
3	Myocardial Infarction 11/2020 - 06/2013
3	Chronic Disease (Chronic Diseases) 08/2020 - 06/2011
3	Atherosclerotic Plaque (Atheroma) 11/2019 - 07/2010
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2018 - 07/2013
3	Carotid Artery Diseases 07/2018 - 07/2013
3	Overweight 02/2015 - 01/2010
3	Acute Coronary Syndrome 02/2015 - 12/2011
3	Obstructive Sleep Apnea 01/2014 - 01/2014
2	Cardiomyopathies (Cardiomyopathy) 10/2022 - 01/2021
2	Hemorrhage 04/2022 - 01/2022
2	Brain Infarction 04/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

44	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 07/2010
36	LipidsIBA 04/2022 - 12/2010
18	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 10/2008
16	Uric Acid (Urate)IBA 12/2021 - 11/2011
15	Insulin (Novolin)FDA Link 08/2021 - 10/2008
14	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2013
10	Hypoglycemic Agents (Hypoglycemics)IBA 11/2021 - 12/2010
9	oxidized low density lipoproteinIBA 01/2022 - 10/2010
8	AdipokinesIBA 07/2018 - 11/2011
7	HDL CholesterolIBA 01/2022 - 04/2012
7	C-Reactive ProteinIBA 01/2022 - 10/2014
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2011
7	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2021 - 11/2012
7	Lipoprotein(a)IBA 05/2021 - 01/2014
7	Ezetimibe (Zetia)FDA Link 03/2018 - 10/2010
6	LDL CholesterolIBA 01/2022 - 01/2013
6	Pioglitazone (Actos)FDA Link 01/2020 - 12/2010
6	Pharmaceutical PreparationsIBA 01/2019 - 11/2011
6	Atorvastatin (Lipitor)FDA Link 01/2014 - 08/2012
5	Lipoproteins (Lipoprotein)IBA 02/2022 - 03/2013
5	CytokinesIBA 11/2020 - 07/2013
5	empagliflozinIBA 11/2020 - 01/2017
5	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2014
5	AdiponectinIBA 01/2019 - 01/2011
4	CholesterolIBA 01/2022 - 12/2011
4	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2021 - 01/2016
4	AntioxidantsIBA 01/2021 - 02/2009
4	SodiumIBA 11/2019 - 01/2016
4	EnzymesIBA 01/2019 - 09/2013
4	LeptinIBA 07/2018 - 01/2011
4	Simvastatin (Zocor)FDA LinkGeneric 01/2014 - 10/2010
3	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2022 - 01/2014
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2018
3	semaglutideIBA 01/2022 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2015
3	Apolipoproteins B (ApoB)IBA 01/2020 - 01/2018
3	ApolipoproteinsIBA 01/2020 - 02/2015
3	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 12/2010
3	Liraglutide FDA Link 01/2019 - 01/2016
3	Alanine Transaminase (SGPT)IBA 01/2019 - 01/2011
3	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2019 - 01/2010
3	Antihypertensive Agents (Antihypertensives)IBA 06/2018 - 01/2014
3	VitaminsIBA 12/2017 - 02/2009
3	Vitamin D FDA LinkGeneric 02/2017 - 01/2014
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2014 - 01/2013
3	Peptides (Polypeptides)IBA 03/2013 - 01/2011
3	GhrelinIBA 01/2012 - 01/2011
2	CreatinineIBA 12/2022 - 01/2019
2	CarbohydratesIBA 06/2022 - 01/2019

Therapy/Procedure

23	Therapeutics 10/2022 - 10/2010
6	Glycemic Control 01/2018 - 12/2010
5	Drug Therapy (Chemotherapy) 01/2020 - 07/2014
4	Carotid Endarterectomy 11/2022 - 01/2018
4	Percutaneous Coronary Intervention 01/2018 - 08/2011
3	Vascular Surgical Procedures 11/2022 - 05/2021
3	Secondary Prevention 01/2017 - 02/2009
2	Mediterranean Diet 06/2022 - 11/2019
2	Blood Component Removal (Apheresis) 02/2022 - 01/2021